Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapts
(NQ:
ACRS
)
9.380
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
9.380
Bid (Size)
7.500 (3)
Ask (Size)
10.10 (4)
Prev. Close
9.380
Today's Range
9.380 - 9.380
52wk Range
5.770 - 18.96
Shares Outstanding
70,679,395
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aclaris Therapeutics Earnings Perspective: Return On Capital Employed
May 22, 2023
Via
Benzinga
Aclaris Therapeutics's Earnings Outlook
May 05, 2023
Via
Benzinga
Performance
YTD
-37.76%
-37.76%
1 Month
+11.67%
+11.67%
3 Month
+19.04%
+19.04%
6 Month
-38.21%
-38.21%
1 Year
-39.21%
-39.21%
More News
Read More
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Via
InvestorPlace
(ACRS) - Analyzing Aclaris Therapeutics's Short Interest
March 08, 2023
Via
Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
March 07, 2023
Via
Benzinga
Analyst Ratings for Aclaris Therapeutics
March 07, 2023
Via
Benzinga
Why Aclaris Therapeutics Is Crashing Today
March 06, 2023
Via
The Motley Fool
Why Aclaris Therapeutics Stock Is Plunging Today
March 06, 2023
Via
Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 07, 2023
Via
Benzinga
DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
March 07, 2023
Via
Benzinga
Aclaris Therapeutics's Return On Capital Employed Insights
February 27, 2023
Via
Benzinga
Looking Into Aclaris Therapeutics's Return On Capital Employed
December 05, 2022
Via
Benzinga
These 2 Biotech Stocks Made Big Monday Moves
March 06, 2023
Via
The Motley Fool
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
March 06, 2023
Via
Benzinga
As Focus Shifts From Hidradenitis Suppurativa, Analyst Seems Bullish On Aclaris
March 06, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
Via
Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
Via
Benzinga
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
March 06, 2023
Via
Benzinga
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January
March 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via
Benzinga
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
December 04, 2022
Via
Talk Markets
10 Best Stocks to Buy Now in December
December 01, 2022
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.